Doral and stevens-johnson syndrome Patient Reports February 13, 2012

Doral Side Effects Report #4936717-X
Doral side effect was reported by a Consumer or non-health professional from JAPAN on Feb 17, 2006. Female patient, 36 years of age, was diagnosed with ill-defined disorder and was treated with Doral. After drug was administered, patient experienced the following side effects: oculomucocutaneous syndrome, stevens-johnson syndrome. Doral dosage: 15 MG, 1 IN 1 D, ORAL. Patient recovered.

Doral Side Effects Report #6024945-4
Doral side effect was reported by a Physician from JAPAN on Dec 04, 2008. Female patient, 18 years of age, was treated with Doral. After drug was administered, patient experienced the following side effects: hepatic function abnormal, mucous membrane disorder, stevens-johnson syndrome. Doral dosage: unknown. During the same period patient was treated with AMOXAPINE, ERISPAN, LUVOX, ROHYPNOL, SEROQUEL, SOLANEX. Patient was hospitalized. Patient recovered.